Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating neoadjuvant FOLFOXIRI chemotherapy alone for locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED